CagriSema 2,4 mg/2,4 mg de Novo Nordisk ha demostrado efectos significativos en la reducción de la HbA1c y el peso corporal en múltiples estudios del programa REIMAGINE.
Plainsboro, NJ y Baggesworth, Dinamarca, 7 de junio de 2026 /PRNewswire/ -- Novo Nordisk anunció hoy los resultados de la Fase 3 de su ensayo REIMAGINE 1-3, que muestran reduccione…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Preguntas frecuentes
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
